Join Eisai’s Webinar on Narcolepsy: Latest Research and Future Directions in Sleep Medicine
- has announced its sponsorship of a webinar titled "Lessons Learned from Central Disorders of Hypersomnolence and Future Directions." This event, hosted by the Sleep Research Society Foundation (SRSF),...
- Narcolepsy is frequently misunderstood and misdiagnosed, leading to delays in treatment and a decreased quality of life for patients.
- Lynn Kramer, MD, Chief Clinical Officer at Eisai, emphasized the company's commitment to narcolepsy research and the importance of educating healthcare providers for better patient support.
Eisai Inc. Sponsors Webinar on Narcolepsy and Hypersomnolence
NUTLEY, N.J., Nov. 21, 2024 /PRNewswire/ – Eisai Inc. has announced its sponsorship of a webinar titled “Lessons Learned from Central Disorders of Hypersomnolence and Future Directions.” This event, hosted by the Sleep Research Society Foundation (SRSF), is the first in the “SRSF State of the Science” educational series. It aims to improve knowledge and best practices in sleep medicine.
Narcolepsy is frequently misunderstood and misdiagnosed, leading to delays in treatment and a decreased quality of life for patients. This webinar will gather experts to share the latest research, treatment options, and management strategies for hypersomnolence disorders.
Webinar Details:
- Date: December 2
- Time: 8:30-10:00 am CT / 9:30-11:00 am ET
Topics Covered:
- Basics of sleep-wake and circadian physiology.
- Identification of signs and symptoms of hypersomnolence disorders like narcolepsy.
- Current treatments and future strategies involving compounds like orexin agonists.
- Impact of advancements on sleep medicine.
Featured Speakers Include:
- Anne Marie Morse, DO, FAASM, Geisinger Commonwealth Health System (Facilitator)
- Atul Malhotra, MD, FAASM, University of California San Diego
- Emmanuel Mignot, MD, PhD, Stanford University
- Phyllis C. Zee, MD, PhD, Northwestern Medicine
Lynn Kramer, MD, Chief Clinical Officer at Eisai, emphasized the company’s commitment to narcolepsy research and the importance of educating healthcare providers for better patient support.
While narcolepsy affects about 25-60 per 100,000 people, it significantly impacts daily life and is linked to increased emergency visits and other health issues such as heart disease and depression.
Philip Gehrman, PhD, President of the Sleep Research Society Foundation, highlighted the importance of this webinar in advancing the conversation on hypersomnolence treatment.
Registration: The event is free but requires registration. Interested participants can register at this link.
About Eisai Inc.: Eisai Inc. focuses on human health care, aiming to improve lives affected by various conditions, including cancer and neurodegenerative diseases.
About the Sleep Research Society Foundation: The foundation supports growth in sleep research and helps investigators secure funding for studies.
About the Sleep Research Society: This professional society promotes sleep science and enhances knowledge to improve health and well-being.
For more information, visit Eisai’s website and the Sleep Research Society Foundation.